↑Katagiri T, Ozaki K, Fujiwara T, Shimizu F, Kawai A, Okuno S, Suzuki M, Nakamura Y, Takahashi E, Hirai Y (dezembro de 1996). «Cloning, expression and chromosome mapping of adducin-like 70 (ADDL), a human cDNA highly homologous to human erythrocyte adducin». Cytogenet Cell Genet. 74 (1–2): 90–5. PMID8893809. doi:10.1159/000134389
Maruyama K, Sugano S (1994). «Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides». Gene. 138 (1–2): 171–4. PMID8125298. doi:10.1016/0378-1119(94)90802-8
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). «Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library». Gene. 200 (1–2): 149–56. PMID9373149. doi:10.1016/S0378-1119(97)00411-3
Gocke CB, Yu H, Kang J (2005). «Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates». J. Biol. Chem. 280 (6): 5004–12. PMID15561718. doi:10.1074/jbc.M411718200
Lanzani C, Citterio L, Jankaricova M, et al. (2005). «Role of the adducin family genes in human essential hypertension». J. Hypertens. 23 (3): 543–9. PMID15716695. doi:10.1097/01.hjh.0000160210.48479.78
Yenerel MN, Sundell IB, Weese J, et al. (2005). «Expression of adducin genes during erythropoiesis: a novel erythroid promoter for ADD2». Exp. Hematol. 33 (7): 758–66. PMID15963851. doi:10.1016/j.exphem.2005.03.015
Olsen JV, Blagoev B, Gnad F, et al. (2006). «Global, in vivo, and site-specific phosphorylation dynamics in signaling networks». Cell. 127 (3): 635–48. PMID17081983. doi:10.1016/j.cell.2006.09.026